Literature DB >> 34117857

Cholesterol metabolism and tumor.

Ying Meng1, Qifei Wang1, Zhimin Lyu1.   

Abstract

Cholesterol is an important lipid in the body of mammals and an essential component of membrane structures. Cholesterol homeostasis is critical for the maintenance of cellular and body activities, and is mainly regulated by the balance of cholesterol biosynthesis and the exogenous cholesterol uptake. Aberrantly regulated cholesterol metabolism promotes tumor cell proliferation,survival,invasion and metastasis,and their adaptability into the tumor microenvironment. Therefore,targeting cholesterol biosynthesis and reduction of plasma cholesterol levels and cholesterol esterification will provide new strategies for cancer treatment. This review summarizes the current understanding in cholesterol homeostasis regulation and its function in the occurence and development of cancer,as well as current metabolism-targeted cancer treatments.

Entities:  

Keywords:  Cholesterol; Metabolism; Review; Therapy; Tumor

Mesh:

Substances:

Year:  2021        PMID: 34117857      PMCID: PMC8675069          DOI: 10.3724/zdxbyxb-2021-0033

Source DB:  PubMed          Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban        ISSN: 1008-9292


  67 in total

Review 1.  Regulation of intestinal lipid metabolism: current concepts and relevance to disease.

Authors:  Chih-Wei Ko; Jie Qu; Dennis D Black; Patrick Tso
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-02-03       Impact factor: 46.802

2.  Analysis of Oxysterols.

Authors:  Fabien Riols; Justine Bertrand-Michel
Journal:  Methods Mol Biol       Date:  2018

Review 3.  Mechanisms and regulation of cholesterol homeostasis.

Authors:  Jie Luo; Hongyuan Yang; Bao-Liang Song
Journal:  Nat Rev Mol Cell Biol       Date:  2019-12-17       Impact factor: 94.444

4.  Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical target.

Authors:  Dabin Liu; Chi Chun Wong; Li Fu; Huarong Chen; Liuyang Zhao; Chuangen Li; Yunfei Zhou; Yanquan Zhang; Weiqi Xu; Yidong Yang; Bin Wu; Gong Cheng; Paul Bo-San Lai; Nathalie Wong; Joseph J Y Sung; Jun Yu
Journal:  Sci Transl Med       Date:  2018-04-18       Impact factor: 17.956

Review 5.  Suppression of T cells by myeloid-derived suppressor cells in cancer.

Authors:  Jieying Chen; Yingnan Ye; Pengpeng Liu; Wenwen Yu; Feng Wei; Hui Li; Jinpu Yu
Journal:  Hum Immunol       Date:  2016-12-07       Impact factor: 2.850

Review 6.  The LDL receptor.

Authors:  Joseph L Goldstein; Michael S Brown
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-04       Impact factor: 8.311

Review 7.  Cellular cholesterol trafficking and compartmentalization.

Authors:  Elina Ikonen
Journal:  Nat Rev Mol Cell Biol       Date:  2008-02       Impact factor: 94.444

8.  Lovastatin inhibits human B lymphoma cell proliferation by reducing intracellular ROS and TRPC6 expression.

Authors:  Xiang Song; Bing-Chen Liu; Xiao-Yu Lu; Li-Li Yang; Yu-Jia Zhai; Amity F Eaton; Tiffany L Thai; Douglas C Eaton; He-Ping Ma; Bao-Zhong Shen
Journal:  Biochim Biophys Acta       Date:  2014-02-08

9.  Effects of dalcetrapib in patients with a recent acute coronary syndrome.

Authors:  Gregory G Schwartz; Anders G Olsson; Markus Abt; Christie M Ballantyne; Philip J Barter; Jochen Brumm; Bernard R Chaitman; Ingar M Holme; David Kallend; Lawrence A Leiter; Eran Leitersdorf; John J V McMurray; Hardi Mundl; Stephen J Nicholls; Prediman K Shah; Jean-Claude Tardif; R Scott Wright
Journal:  N Engl J Med       Date:  2012-11-05       Impact factor: 91.245

10.  Serum low-density lipoprotein and low-density lipoprotein expression level at diagnosis are favorable prognostic factors in patients with small-cell lung cancer (SCLC).

Authors:  Ting Zhou; Jianhua Zhan; Wenfeng Fang; Yuanyuan Zhao; Yunpeng Yang; Xue Hou; Zhonghan Zhang; Xiaobo He; Yaxiong Zhang; Yan Huang; Li Zhang
Journal:  BMC Cancer       Date:  2017-04-14       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.